Skip to main content

Advertisement

SpringerLink
Log in

Human papilloma virus and p53 expression in bladder cancer in Egypt: Relationship to schistosomiasis and clinicopathologic factors

  • Article
  • Published:
Pathology & Oncology Research

An Erratum to this article was published on 01 December 2006

Abstract

The aim of the current study was to compare the role of p53 and human papillomavirus (HPV) in schistosomiasis-related and schistosomiasis-unrelated carcinoma of the urinary bladder. To achieve this aim, we investigated 114 bladder carcinomas for p53 oncoprotein expression by immunohistochemistry and for human papillomavirus by in situ hybridization technique. The results revealed that 64 tumors (56.1%) were schistosomiasis-associated. Sixty seven (58.8%) were transitional cell carcinomas and 32 (28%) were squamous cell carcinomas. The remaining 15 tumors (13.2%) included adenocarcinomas and sarcomatoid carcinomas. In both schistosomiasis-associated and non-associated carcinomas, p53 oncoprotein expression was significantly higher in poorly differentiated tumors. However, it was significantly higher in locally more invasive tumors in the schistosomal carcinomas only. HPV types 16/18 could be detected in 1 of the 114 bladder carcinomas (0.95%), which was schistosomiasis-related squamous cell carcinoma in situ. These results suggest that p53 immunohistochemistry can be a prognostic factor in both schistosomal and nonschistosomal bladder cancer. More importantly, HPV does not seem to play a role in the pathogenesis of either type of bladder cancer in our country.(Pathology Oncology Research Vol 12, No 3, 173–178)

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Khaled HM: Bladder cancer and bilharziasis today. Cancer J 6: 65–71, 1993.

    Google Scholar 

  2. El-Bolkainy MN, Ghoneim MA, Mansour MA: Carcinoma of the bilharzial bladder in Egypt. Clinical and pathological features. Br J Urol 44: 561–570, 1972.

    Google Scholar 

  3. El-Sebai I: Cancer of the bilharzial bladder. Urol Res 6: 233–236, 1978.

    Article  CAS  Google Scholar 

  4. El-Merzabani MM, El-Aaser AA, Zakhary NI: A study on the etiological factors of bilharzial bladder cancer in Egypt. 1. Nitrosoamines and their precursors in urine. Eur J Cancer 15: 287–291, 1979.

    PubMed  CAS  Google Scholar 

  5. El-Bolkainy MN, Mokhtar NM, Ghoneim MA, Hussein MH: The impact of schistosomiasis on the pathology of bladder carcinoma. Cancer 48: 2643–2648, 1981.

    Article  PubMed  CAS  Google Scholar 

  6. Mostafa MH, Sheweita SA, O’Connor PJ: Relationship between schistosomiasis and bladder cancer. Clin Microbiol Rev 12: 97–111, 1999.

    PubMed  CAS  Google Scholar 

  7. Wright C, Mellon K, Johnston P, et al. Expression of mutant p53, c-erb B2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder. Br J Cancer 63: 967–970, 1991.

    PubMed  CAS  Google Scholar 

  8. Soini Y, Turpeenniemi-Hujamen T, Kamel D, et al: p53 immunohistochemistry in transitional cell carcinoma and dysplasia of the urinary bladder correlates with disease progression. Br J Cancer 68: 1029–1035, 1993.

    PubMed  CAS  Google Scholar 

  9. Harney J, Murphy DM, Jones M, Mothersill C: Expression of p53 in urothelial cell cultures from tumor-bearing and tumorfree patients. Br J Cancer 71: 25–29, 1995.

    PubMed  CAS  Google Scholar 

  10. Glick SH, Howell LP, White RW: Relationship of p53 and bcl2 to prognosis in muscle-invasive transitional cell carcinoma of the bladder. J Urol 155: 1754–1757, 1996.

    Article  PubMed  CAS  Google Scholar 

  11. Hermann GG, Horn T, Steven K: The influence of the level of lamina propria invasion and the prevalence of p53 nuclear accumulation on survival in stage T1 transitional cell bladder cancer. J Urol 159: 91–94, 1998.

    Article  PubMed  CAS  Google Scholar 

  12. Niehans GA, Kratzke RA, Froberg-MK,et al: G1 check point protein and p53 abnormalities occur in most invasive transitional cell carcinomas of the urinary bladder. Br J Cancer 80: 1175–1184, 1999.

    Article  PubMed  CAS  Google Scholar 

  13. Steiner G, Bierhoff E, Schmidt D, et al: p53 immunoreactivity in biopsy specimens of T1 G3 transitional cell carcinoma of the bladder, a helpful parameter in guiding the decision for or against cystectomy? Eur J Cancer 36: 610–614, 2000.

    Article  PubMed  CAS  Google Scholar 

  14. Habuchi T, Takahashi R, Yamada H, et al: Influence of cigarette smoking and schistosomiasis on p53 gene mutation in urothelial cancer. Cancer Res 53: 3795–3799, 1993.

    PubMed  CAS  Google Scholar 

  15. Kamel D, Soini Y, Nuorva K, et al: p53 and c-erb2 expression in schistosomal urinary bladder carcinomas and schistosomal cystitis with premalignant lesions. Virchows Arch 424: 349–355, 1994.

    Article  PubMed  CAS  Google Scholar 

  16. Warren W, Biggs PJ, El Baz M, et al: Mutations in the p53 gene in schistosomal bladder cancer: a study of 92 tumors from Egyptian patients and a comparison between mutational spectra from schistosomal and non-schistosomal urothelial tumors. Carcinogenesis 16: 1181–1189, 1995.

    Article  PubMed  CAS  Google Scholar 

  17. Ramchurren N, Cooper K, Summerhay IC: Molecular events underlying schistosomiasis-related bladder cancer. Int J Cancer 62: 237–244, 1995.

    Article  PubMed  CAS  Google Scholar 

  18. Chaudhary KS, Abel PD, Khandan-Nia N, et al: Expression of bcl-2 and p53 oncoproteins in schistosomiasis-associated transitional and squamous cell carcinoma of the urinary bladder. Br J Urol 79: 78–84, 1997.

    PubMed  CAS  Google Scholar 

  19. Bryant P, Skelly J, Wilson D: Demonstration of papillomavirus structural antigen in human urinary bladder neoplasia. Br J Urol 60: 405–409, 1987.

    PubMed  CAS  Google Scholar 

  20. Kitamura T, Yogo Y, Ueki T, et al: Presence of human papillomavirus type 16 genome in bladder carcinoma in situ of a patient with mild immunodeficiency. Cancer Res 48: 7207–7211, 1988.

    PubMed  CAS  Google Scholar 

  21. Bryant P, Davies P, Wilson D. Detection of human papillomavirus DNA in cancer of the urinary bladder by in situ hybridization. Br J Urol 68: 49–52, 1991.

    Article  PubMed  CAS  Google Scholar 

  22. Anwar K, Naiki H, Nakakuki K, Inuzuka M: High frequency of human papillomavirus infection in carcinoma of the urinary bladder. Cancer 70: 1967–1973, 1992.

    Article  PubMed  CAS  Google Scholar 

  23. Chetsange C, Malnstrom PU, Gyllensten U, et al: Low incidence of human papillomavirus type 16 DNA in bladder tumor detected by the polymerase chain reaction. Cancer 69: 1208–1211, 1992.

    Google Scholar 

  24. Lopez-Beltron A, Munoz E: Transitional cell carcinoma of the bladder: low incidence of human papillomavirus DNA detected by the polymerase chain reaction and in situ hybridization. Histopathology 26: 565–569, 1995.

    Article  Google Scholar 

  25. Tenti P, Zappatore R, Roagnoli S, et al: p53 overexpression and human papillomavirus infection in transitional cell carcinoma of the urinary bladder: correlation with histological parameters. J Pathol 178: 65–70, 1996.

    Article  PubMed  CAS  Google Scholar 

  26. Cooper K, Haffajee Z, Taylor L: Human papillomavirus and schistosomiasis associated bladder cancer. Mol Pathol 50: 145–148, 1997.

    Article  PubMed  CAS  Google Scholar 

  27. Guidici C, Ferrario D, Forlni N, et al: Study of human papillomavirus via chemiluminescence technique and polymerase chain reaction in transitional cell carcinoma of the bladder. Pathologica 90: 776–782, 1998.

    Google Scholar 

  28. Aynaud O, Tranboloc P, Orth G: Lack of evidence for a role of human papillomavirus in transitional cell carcinoma of the bladder. J Urol 159: 86–89, 1998.

    Article  PubMed  CAS  Google Scholar 

  29. Simoneau M, La Rue H, Fradet Y. Low frequency of human papillomavirus in initial papillary bladder tumors. Urol Res 27: 180–184, 1999.

    Article  PubMed  CAS  Google Scholar 

  30. De-Goetani C, Ferrori G, Righi E, et al: Detection of human papillomavirus DNA in urinary bladder carcinoma by in situ hybridization. J Clin Pathol 52: 103–106, 1999.

    Google Scholar 

  31. Khaled HM, Raafat A, Mokhtar N, et al: Human papillomavirus infection and overexpression of p53 protein in bilharzial bladder cancer. Tumori 87: 256–261, 2001.

    PubMed  CAS  Google Scholar 

  32. Mostofi FK, Sobin LH, Torloni H: Histologic typing of urinary bladder tumors. In: International Histological Classification of Tumors (Vol10). WHO, Geneva, 1973.

    Google Scholar 

  33. Mostofi FK, Davis CJ, Sestrhenn IA: Histologic typing of urinary bladder tumors. In: World Health Organization International Histological Classification of Tumors 2nd ed. Heidelberg, Germany: Springer Verlag, Berlin, 1999.

    Google Scholar 

  34. Fleming ID, Cooper JS, et al (eds): AJCC Manual for Staging of Cancer. 5th ed., Lippincott Raven, Philadelphia, PA, 1997.

    Google Scholar 

  35. Hsu SM, Raine L: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase technique. A comparison between ABC and unlabelled (PAP) procedures. J Hischochem Cytochem 29: 577–580, 1981.

    CAS  Google Scholar 

  36. Gabert HE, Muller W, Schneiders A, et al: The relationship of p53 expression to the prognosis of 418 patients with gastric carcinoma. Cancer 76: 720–726, 1995.

    Article  Google Scholar 

  37. Krager B: Preparation and use of biotinylated oligonucleotide probes. Focus 11: 57–58, 1989.

    Google Scholar 

  38. Ross RK, Jones PA, Yu MC: Bladder cancer: Epidemiology and pathogenesis. Semin Oncol 23:536–545, 1996.

    PubMed  CAS  Google Scholar 

  39. Koroltchouk V, Stanley K, Stjinsward J, Mott K: Bladder cancer: approaches to prevention and control. Bull World Health Organ 65: 513–520, 1987.

    PubMed  CAS  Google Scholar 

  40. Plastiras D, Moutzouris G, Barbatis C, et al: Can p53 nuclear over-expression, bcl2 accumulation and PCNA status be of prognostic significance in high risk superficial and invasive bladder tumors? Eur J Surg Oncol 25: 61–65, 1999.

    Article  PubMed  CAS  Google Scholar 

  41. Herr HW, Bajorin DF, Scher HI, et al: Can p53 help select patients with invasive bladder cancer for bladder preservation. J Urol 161: 20–22, 1999.

    Article  PubMed  CAS  Google Scholar 

  42. Llopis J, Alcaraz A, Ribal MJ, et al: p53 expression predicts progression and poor survival in T1 bladder tumors. Eur Urol 37: 644–653, 2000.

    Article  PubMed  CAS  Google Scholar 

  43. La Rue H, Simoneau M, Fradet Y. Human papillomavirus in transitional cell carcinoma of the urinary bladder. Clin Cancer Res 1: 435–440, 1995.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Faculty of Medicine, Ain-Shams University, Cairo, Egypt

    Thanaa El A Helal & Mona T Fadel

  2. Department of Zoology, Faculty of Science, Cairo University, Cairo, Egypt

    Naglaa K El-sayed

Authors
  1. Thanaa El A Helal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mona T Fadel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Naglaa K El-sayed
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thanaa El A Helal.

Additional information

An erratum to this article is available at http://dx.doi.org/10.1007/BF02893418.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Helal, T.E.A., Fadel, M.T. & El-sayed, N.K. Human papilloma virus and p53 expression in bladder cancer in Egypt: Relationship to schistosomiasis and clinicopathologic factors. Pathol. Oncol. Res. 12, 173–178 (2006). https://doi.org/10.1007/BF02893365

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02893365

Key words

Search

Navigation